A carregar...

Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer

Ilana Schlam,1 Raquel Nunes,2 Filipa Lynce3 1Department of Hematology and Oncology, Tufts Medical Center, Boston, MA, USA; 2Johns Hopkins Women’s Malignancies Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 3Breast Medical Oncology, Dana Farber Cancer Institute, Boston, MA,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schlam I, Nunes R, Lynce F
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2022-04-01
Colecção:OncoTargets and Therapy
Assuntos:
Acesso em linha:https://www.dovepress.com/profile-of-margetuximab-evidence-to-date-in-the-targeted-treatment-of--peer-reviewed-fulltext-article-OTT
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!